World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
29959
World Ranking
14034
National Ranking
1299

Overview

Giancarlo Viberti is affiliated with King's College London in the United Kingdom. Their research primarily focuses on Medicine, with specialization in Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism.

Their recent work includes several papers published in prominent journals. These publications include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021, The Lancet)
  • Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis (2025, European Heart Journal)
  • P.64 Active Vitamin D Treatment Does Not Improve Arterial Stiffness and Markers of Cardio-Renal Risk in Patients with Type 2 Diabetes and Stage 3 Chronic Kidney Disease: a Randomised Controlled Trial (2020, Artery Research)

The main topics covered in their work are:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiac Health and Mental Health
  • Hormonal Regulation and Hypertension

Frequent co-authors collaborating with Giancarlo Viberti include:

  • Kazem Rahimi
  • Zeinab Bidel
  • Milad Nazarzadeh
  • Dexter Canoy
  • Mark Woodward

Their research is often published in venues such as:

  • The Lancet
  • European Heart Journal
  • Artery Research

This profile highlights Giancarlo Viberti's focus on cardiovascular research, particularly related to blood pressure management and the interplay between cardiac and metabolic health. Their contributions include collaborative meta-analyses and clinical trials that explore pharmacological and biochemical interventions in these fields.

Best Publications

  • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn Se;Haffner Sm;Heise Ma;Herman Wh

  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz

  • Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus A Blood Pressure–Independent Effect

    Giancarlo Viberti;Nigel M. Wheeldon

  • Prevention of diabetic renal disease with special reference to microalbuminuria

    Carl Erik Mogensen;William F. Keane;Peter H. Bennett;George Jerums

  • Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria

    G Viberti;C E Mogensen;L C Groop;J F Pauls

  • Rosiglitazone-associated Fractures in Type 2 Diabetes: An Analysis From A Diabetes Outcome Progression Trial (ADOPT)

    Steven E. Kahn;Bernard Zinman;John M. Lachin;Steven M. Haffner

  • Prospective study of microalbuminuria as predictor of mortality in NIDDM.

    Martin B Mattock;Nicholas J Morrish;Giancarlo Viberti;Harry Keen

  • Avosentan for Overt Diabetic Nephropathy

    Johannes F.E. Mann;Damian Green;Kenneth Jamerson;Luis M. Ruilope

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

    Ruggero Mangili;Jeremy J. Bending;Graham Scott;Lai K. Li

  • Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

    Viberti Gc;Pickup Jc;Jarrett Rj;Keen H

  • Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study

    J W Messent;T G Elliott;R D Hill;R J Jarrett

  • Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria

    Kathryn E. White;Rudolf W. Bilous;Sally M. Marshall;Meguid El Nahas

  • A Diabetes Outcome Progression Trial (ADOPT) An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

    Giancarlo Viberti;Steven E. Kahn;Douglas A. Greene;William H. Herman

  • Rosiglitazone reduces urinary albumin excretion in type II diabetes.

    G Bakris;G Viberti;W M Weston;M Heise

  • Pathogenesis of diabetic nephropathy.

    A E Raptis;Gian-Carlo Viberti

  • Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

    J. Yip;M. B. Mattock;A. Morocutti;Meera Sethi

  • Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes Preterax in Albuminuria Regression: PREMIER

    Carl Erik Mogensen;Giancarlo Viberti;Serge Halimi;Eberhard Ritz

  • Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

    Kenneth Earle;James Walker;Caron Hill;GianCarlo Viberti

  • The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

    Dick De Zeeuw;Blai Coll;Dennis Andress;John J. Brennan

Frequent Co-Authors

Harry Keen
Harry Keen Guy's Hospital
Eberhard Ritz
Eberhard Ritz Heidelberg University
Rury R. Holman
Rury R. Holman University of Oxford
Luis M. Ruilope
Luis M. Ruilope European University of Madrid
Steven E. Kahn
Steven E. Kahn University of Washington
Hermann Haller
Hermann Haller Hannover Medical School
Ton J. Rabelink
Ton J. Rabelink Leiden University Medical Center
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
John M. Lachin
John M. Lachin George Washington University
Bernard Zinman
Bernard Zinman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers many alternative pathways for those seeking flexibility or looking to advance their careers online. Healthcare professionals can now pursue an online mha program to move into administrative and leadership roles without disrupting their work schedule. These programs are designed for convenience, letting you balance professional and academic demands.

For registered nurses interested in earning a bachelor’s degree, there are now rn to bsn with no clinicals options, allowing RNs to study online and complete their education without additional on-site clinical requirements.

Advanced practice nurses who want to further their education quickly can choose accelerated msn to dnp programs, which fast-track doctoral training in nursing.

Additionally, for those seeking a smooth transition to doctoral-level nursing, there are dnp programs that are designed for efficiency and accessibility.

These pathways make it easier than ever to grow in the healthcare field, offering flexible and reputable online credentials.

Best Scientists Citing Giancarlo Viberti

Trending Scientists

Recently Published Articles